Press release |

07 October 2020

In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic

Governments make request to WTO for intellectual property waiver for all countries until herd immunity reached

COVID-19

Photograph by Jacob Burns

Latest news

Statement |

16 October 2020

MSF statement supporting the extension of TRIPS exemption for least-developed countries

Letter |

15 October 2020

United Kingdom

Joint UK civil society letter to UK government calling for support for India and South Africa's WTO waiver proposal

Letter |

15 October 2020

Civil society to WTO members: Support India and South Africa’s proposal for a waiver from IP protections for COVID-19 medical technologies

Press release |

14 October 2020

MSF response to the release of WHO Global TB Report 2020

Feature story |

11 October 2020

5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response

Technical brief |

09 October 2020

Global

India and South Africa proposal for WTO waiver from IP protections for COVID-19-related medical technologies

Statement |

05 October 2020

MSF Statement for WHO Executive Board Special Session on COVID-19 Response

Technical brief |

30 September 2020

Global

Voluntary licenses and access to medicines

Technical brief |

29 September 2020

United Kingdom

MSF submission to APPG on Coronavirus Inquiry into the UK Government’s handling of the coronavirus outbreak

Statement |

22 September 2020

Europe

MSF statement at EU Parliament hearing on COVID-19 vaccines

Technical brief |

14 September 2020

MSF Position on the European Commission’s Roadmap for Pharmaceutical Strategy

Technical brief |

23 August 2020

Global

Access Challenges to COVID-19 Therapeutic Candidates

MSF Access Campaign work on COVID-19

Feature story

Feature story |

11 October 2020

COVID-19

5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response

4 min

Spotlight

Spotlight |

22 June 2020

COVID-19

COVID-19 vaccine: 6 recommendations for equitable access

4 min

COVID-19

COVID-19 Action for access

Get involved!

Hospital installed by MSF to treat coronavirus patients in Leganes.

Press release

Press release |

27 March 2020

COVID-19

MSF calls for no patents or profiteering on COVID-19 drugs, tests, and vaccines in pandemic

4 min

Technical brief |

09 October 2020

COVID-19

India and South Africa proposal for WTO waiver from IP protections for COVID-19-related medical technologies

Statement

Statement |

05 October 2020

COVID-19

Global

MSF Statement for WHO Executive Board Special Session on COVID-19 Response

Technical brief |

29 September 2020

COVID-19

United Kingdom

MSF submission to APPG on Coronavirus Inquiry into the UK Government’s handling of the coronavirus outbreak

Statement |

22 September 2020

COVID-19

MSF statement at EU Parliament hearing on COVID-19 vaccines

Video |

20 May 2020

COVID-19: No patents or profiteering in a pandemic

Video |

05 April 2020

No monopolies - Access to COVID-19 treatment

Video

Johnson & Johnson: Can you hear us?

Video

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Video

A Snapshot of the Access Campaign

COVID-19: No patents or profiteering in a pandemic

No monopolies - Access to COVID-19 treatment

Johnson & Johnson: Can you hear us?

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

A Snapshot of the Access Campaign

What good is a breakthrough medicine if the people who need it can't afford it?

20 Years of Advocacy in Action - JOIN US!

Our work

COVID-19

Drug-resistant infections

Diabetes

Hepatitis C

HIV/AIDS

Tropical & neglected diseases

Tuberculosis

Vaccines

Patents & intellectual property

Research & development

Read, watch, share

Feature story

Feature story |

11 October 2020

COVID-19

5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response

4 min

Spotlight |

05 October 2020

Intellectual property and trade

Spotlight

Patent Oppositions Database

Spotlight

Spotlight |

22 June 2020

COVID-19

COVID-19 vaccine: 6 recommendations for equitable access

4 min

COVID-19

COVID-19 Action for access

Get involved!

Feature story

Feature story |

23 March 2020

Tuberculosis

5 barriers from Big Pharma preventing people getting lifesaving TB drugs

3 min

Spotlight

Spotlight |

15 February 2020

Research and development

How Big Pharma is making people pay twice for many of the medicines they buy

Emmily Mkumba’s mobility is severely limited by her sickness; she still manages to make the long trip from the township of Machinjiri to Blantyre for her bi-weekly chemotherapy sessions, but relies on visits by the MSF palliative care team for pain management.

Feature story

Feature story |

09 July 2020

Vaccines

Malawi

A silent woman-killer in Malawi

11 min

Video

Video |

01 July 2020

Diabetes

Access to Insulin: Towards a WHA Resolution

Join the conversation

Video

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

🌟Read and share our wishes

Get Involved!

🌟Read and share our wishes

Get Involved!

Get Involved!

🌟Read and share our wishes

Get Involved!

🌟Read and share our wishes

Get Involved!

🌟Read and share our wishes

Get Involved!

Get Involved!

🌟Read and share our wishes

Get Involved!

No patents or profiteering on drugs, tests, and vaccines in pandemic

Homepage

Latest news

MSF statement supporting the extension of TRIPS exemption for least-developed countries

Joint UK civil society letter to UK government calling for support for India and South Africa's WTO waiver proposal

Civil society to WTO members: Support India and South Africa’s proposal for a waiver from IP protections for COVID-19 medical technologies

MSF response to the release of WHO Global TB Report 2020

5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response

India and South Africa proposal for WTO waiver from IP protections for COVID-19-related medical technologies

MSF Statement for WHO Executive Board Special Session on COVID-19 Response

Voluntary licenses and access to medicines

MSF submission to APPG on Coronavirus Inquiry into the UK Government’s handling of the coronavirus outbreak

MSF statement at EU Parliament hearing on COVID-19 vaccines

MSF Position on the European Commission’s Roadmap for Pharmaceutical Strategy

Access Challenges to COVID-19 Therapeutic Candidates

MSF Access Campaign work on COVID-19

Our work

Read, watch, share

Join the conversation

Don't miss out!